ASHS
Democratizing Healthcare Technology and Equipment

Modern medical technology seems to be a double-edged sword than just the key to a bright future. It is praised for saving lives, improving people’s health, and raising the standard of patient care delivery; the same is also considered a major reason for the exponential rise in medical expenses. ‘Big-ticket’ items, particularly radiation oncology equipment, organ transplantation procedures, and diagnostic imaging systems, attract attention as extremely useful but incredibly expensive commodities. Even the most successful healthcare facilities have their fair share of financial limitations, preventing them from independently acquiring expensive medical systems. To overcome these constraints, healthcare institutions are looking for a proactive and trustworthy partner to assist them in procuring capital-intensive yet necessary medical equipment. Fortunately, they do not have to look for long as the search ends with American Shared Hospital Services (ASHS).

Having been in the industry for over 30 years, ASHS excels at providing turnkey medical financing solutions, granting clinical partners affordable access to cutting-edge radiation oncology equipment in a creative and flexible manner.

“Our mission is to advance the quality of healthcare by bringing breakthrough technologies to many institutions and helping them best serve their communities,” states Ray Stachowiak, CEO of ASHS. The company strives to extend a hospital’s acquisition capabilities through comprehensive financing solutions that help meet the facility’s unique equipment needs. Its flexible options, such as joint ventures, fee-for-use, revenue sharing, and full turnkey services, in tandem with its end-to-end support from seasoned industry experts, are perfectly poised to support clients in any financial situation.

The team at ASHS ensures that they help customers every step of the way, from feasibility studies and installations all the way through to marketing and delivering educational support.

A primary concern in the healthcare sector revolves around the fact that technological advancement is simply too quick. Healthcare organizations are often uncertain about using or abandoning their existing, expensive piece of equipment. ASHS solves such issues by providing state-of-the-art medical equipment to hospitals and medical centers across the United States and abroad. Going the extra mile, ASHS shares the reimbursement risk post acquisition of the equipment.

As a leading provider of radiation therapy equipment, the company has the talent, knowledge, and infrastructure to efficiently provide maximum benefit to finance linear accelerators (LINACs), Gamma Knives, and proton beam radiation therapy (PBRT) that provide clinical application, such as intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), volumetric modulated arc therapy (VMAT), and stereotactic radiosurgery (SRS). Apart from offering these services, ASHS also takes care of equipment insurance and property taxes and works with hospital systems to strengthen their effort in the operations and marketing of their center.

It is interesting to note that ASHS first buys expensive equipment from large OEMs such as Varian (owned by Siemens) and then provides it to healthcare institutions, bolstering their ability to deliver the best patient care. Moving forward, ASHS is planning to forge more partnerships to serve its clinical partners better. ASHS is also excited to have Tim Keel as its head of sales and marketing. The VP is well known in the industry as a healthcare financial specialist, and his efforts are supported by ASHS’ substantial resources. “At the end of our second quarter 2022, ASHS had $12 million in cash and an unused credit line of $7 million. These assets can be further leveraged to invest over $100 million in radiation oncology equipment, facilities and services all in an effort to help people fight cancer,” exclaimed Stachowiak. With such capabilities and experience, ASHS is well-positioned for future growth.